(UBS) UBS - Ratings and Ratios
Investment Advice, Wealth Planning, Banking, Investment Management, Lending
UBS EPS (Earnings per Share)
UBS Revenue
Description: UBS UBS
UBS Group AG is a global financial services company providing a wide range of financial solutions to private, institutional, and corporate clients. The companys diverse business model is organized into five divisions: Global Wealth Management, Personal & Corporate Banking, Asset Management, Investment Bank, and Non-core and Legacy. This structure enables UBS to offer comprehensive financial services, including investment advice, wealth planning, corporate banking, and investment management.
Key Performance Indicators (KPIs) that can be used to evaluate UBSs performance include revenue growth, net profit margin, return on equity (RoE), and cost-income ratio. With a RoE of 5.86%, UBS is generating returns that are somewhat modest compared to some of its peers, suggesting there may be opportunities for improvement in profitability. The companys diversified business model is a strength, as it allows UBS to capitalize on various market opportunities and manage risks across different business lines.
UBSs Asset Management and Investment Bank divisions are critical components of its business, providing a range of products and services such as equities, fixed income, hedge funds, and alternative investment strategies. The companys ability to offer customized multi-asset solutions and advisory services is a key differentiator. Additionally, UBSs Global Wealth Management division is a significant contributor to its revenue, providing wealth management services to high net worth individuals.
From a valuation perspective, UBSs price-to-earnings (P/E) ratio of 22.36 and forward P/E of 17.92 suggest that the stock may be moderately valued relative to its earnings. The companys market capitalization of $107.65 billion indicates a significant presence in the global financial services industry. Overall, UBSs diversified business model, global reach, and range of financial services position it as a major player in the industry.
UBS Stock Overview
| Market Cap in USD | 127,369m |
| Sub-Industry | Diversified Capital Markets |
| IPO / Inception | 2014-11-21 |
UBS Stock Ratings
| Growth Rating | 88.8% |
| Fundamental | 55.4% |
| Dividend Rating | 49.5% |
| Return 12m vs S&P 500 | 16.4% |
| Analyst Rating | 2.50 of 5 |
UBS Dividends
| Dividend Yield 12m | 3.80% |
| Yield on Cost 5y | 13.46% |
| Annual Growth 5y | -6.39% |
| Payout Consistency | 87.9% |
| Payout Ratio | 59.8% |
UBS Growth Ratios
| Growth Correlation 3m | 94.9% |
| Growth Correlation 12m | 69.7% |
| Growth Correlation 5y | 95.9% |
| CAGR 5y | 32.37% |
| CAGR/Max DD 5y | 1.00 |
| Sharpe Ratio 12m | 1.38 |
| Alpha | 14.93 |
| Beta | 1.336 |
| Volatility | 24.44% |
| Current Volume | 1525.7k |
| Average Volume 20d | 1744.7k |
| Stop Loss | 39.3 (-3.2%) |
| Signal | 1.90 |
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (6.28b TTM) > 0 and > 6% of Revenue (6% = 3.06b TTM) |
| FCFTA 0.11 (>2.0%) and ΔFCFTA 5.97pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -994.5% (prev -1189 %; Δ 194.6pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.11 (>3.0%) and CFO 185.93b > Net Income 6.28b (YES >=105%, WARN >=100%) |
| Net Debt (204.02b) to EBITDA (17.73b) ratio: 11.50 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.45 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (3.31b) change vs 12m ago -1.57% (target <= -2.0% for YES) |
| Gross Margin 37.42% (prev 98.78%; Δ -61.36pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 3.16% (prev 2.87%; Δ 0.29pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.46 (EBITDA TTM 17.73b / Interest Expense TTM 30.67b) >= 6 (WARN >= 3) |
Altman Z'' -1.72
| (A) -0.30 = (Total Current Assets 410.45b - Total Current Liabilities 917.96b) / Total Assets 1669.99b |
| (B) 0.05 = Retained Earnings (Balance) 79.73b / Total Assets 1669.99b |
| (C) 0.01 = EBIT TTM 14.12b / Avg Total Assets 1615.48b |
| (D) 0.05 = Book Value of Equity 85.55b / Total Liabilities 1580.29b |
| Total Rating: -1.72 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 55.39
| 1. Piotroski 3.50pt = -1.50 |
| 2. FCF Yield 79.51% = 5.0 |
| 3. FCF Margin data missing |
| 4. Debt/Equity 3.81 = -1.83 |
| 5. Debt/Ebitda 19.17 = -2.50 |
| 6. ROIC - WACC -1.56% = -1.95 |
| 7. RoE 7.21% = 0.60 |
| 8. Rev. Trend 82.23% = 4.11 |
| 9. Rev. CAGR 36.13% = 2.50 |
| 10. EPS Trend -13.51% = -0.34 |
| 11. EPS CAGR 13.02% = 1.30 |
What is the price of UBS shares?
Over the past week, the price has changed by +2.81%, over one month by +7.46%, over three months by +28.52% and over the past year by +37.02%.
Is UBS a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of UBS is around 49.82 USD . This means that UBS is currently undervalued and has a potential upside of +22.71% (Margin of Safety).
Is UBS a buy, sell or hold?
- Strong Buy: 0
- Buy: 0
- Hold: 1
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the UBS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 35.1 | -13.5% |
| Analysts Target Price | 35.1 | -13.5% |
| ValueRay Target Price | 53.3 | 31.4% |
Last update: 2025-08-26 02:46
UBS Fundamental Data Overview
CCE Cash And Equivalents = 236.19b USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 21.2646
P/E Forward = 21.7865
P/S = 2.7094
P/B = 1.4334
P/EG = 0.3993
Beta = 0.918
Revenue TTM = 51.03b USD
EBIT TTM = 14.12b USD
EBITDA TTM = 17.73b USD
Long Term Debt = 307.98b USD (from longTermDebt, last quarter)
Short Term Debt = 31.93b USD (from shortTermDebt, last quarter)
Debt = 339.90b USD (Calculated: Short Term 31.93b + Long Term 307.98b)
Net Debt = 204.02b USD (from netDebt column, last quarter)
Enterprise Value = 231.08b USD (127.37b + Debt 339.90b - CCE 236.19b)
Interest Coverage Ratio = 0.46 (Ebit TTM 14.12b / Interest Expense TTM 30.67b)
FCF Yield = 79.51% (FCF TTM 183.72b / Enterprise Value 231.08b)
FCF Margin = 360.0% (FCF TTM 183.72b / Revenue TTM 51.03b)
Net Margin = 12.31% (Net Income TTM 6.28b / Revenue TTM 51.03b)
Gross Margin = 37.42% ((Revenue TTM 51.03b - Cost of Revenue TTM 31.94b) / Revenue TTM)
Tobins Q-Ratio = 2.70 (Enterprise Value 231.08b / Book Value Of Equity 85.55b)
Interest Expense / Debt = 2.01% (Interest Expense 6.82b / Debt 339.90b)
Taxrate = 24.56% (from yearly Income Tax Expense: 1.68b / 6.82b)
NOPAT = 10.65b (EBIT 14.12b * (1 - 24.56%))
Current Ratio = 0.45 (Total Current Assets 410.45b / Total Current Liabilities 917.96b)
Debt / Equity = 3.81 (Debt 339.90b / last Quarter total Stockholder Equity 89.28b)
Debt / EBITDA = 19.17 (Net Debt 204.02b / EBITDA 17.73b)
Debt / FCF = 1.85 (Debt 339.90b / FCF TTM 183.72b)
Total Stockholder Equity = 87.14b (last 4 quarters mean)
RoA = 0.38% (Net Income 6.28b, Total Assets 1669.99b )
RoE = 7.21% (Net Income TTM 6.28b / Total Stockholder Equity 87.14b)
RoCE = 3.57% (Ebit 14.12b / (Equity 87.14b + L.T.Debt 307.98b))
RoIC = 2.52% (NOPAT 10.65b / Invested Capital 422.76b)
WACC = 4.08% (E(127.37b)/V(467.27b) * Re(10.94%)) + (D(339.90b)/V(467.27b) * Rd(2.01%) * (1-Tc(0.25)))
Shares Correlation 5-Years: -70.0 | Cagr: -1.93%
Discount Rate = 10.94% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 62.92% ; FCFE base≈141.63b ; Y1≈109.86b ; Y5≈70.13b
Fair Price DCF = 271.5 (DCF Value 860.40b / Shares Outstanding 3.17b; 5y FCF grow -26.71% → 3.0% )
Revenue Correlation: 82.23 | Revenue CAGR: 36.13%
Rev Growth-of-Growth: -8.48
EPS Correlation: -13.51 | EPS CAGR: 13.02%
EPS Growth-of-Growth: 178.0
Additional Sources for UBS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle